Emily Blyth

22PUBLICATIONS
117CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)HaematologyHaematological tumoursEpidemiology not elsewhere classifiedMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Sep 30, 2026
Preventing infections after CD19-directed chimeric antigen receptor T-cell therapies for lymphoma: a consensus practice statement.

|Aug 18, 2026
Immune cell subsets that predict cytomegalovirus reactivation magnitude after haematopoietic stem cell transplantation.

|Apr 15, 2026
Human Cytomegalovirus Infection in Haematopoietic Stem Cell Transplant Recipients and CAR T Cell Recipients - PART 1: Risk Factors, Clinical Impact and Immune Response.

Danya Kaplan, Emily Blyth, Gaurav Sutrave

|Feb 17, 2026
Time of infusion does not significantly impact outcomes following CAR T-cell therapy in large B-cell lymphoma.

Mark R Dowling, Edward Robert Scheffer Cliff, Anthony Jeffrey

|Sep 12, 2025
Human herpesvirus 6 viremia and encephalitis in CAR T-cell recipients.

Stephanie T Isaac, David C Bishop, Fahad Shaikh

|Aug 28, 2025
Interferon-α Nasal Spray Prophylaxis Reduces COVID-19 in Cancer Patients: A Randomized, Double-Blinded, Placebo-Controlled Trial.

Michelle K Yong, Karin Thursky, Megan Crane

Pageof 4

Frequent Collaborators

6 joint publications

Helen Marie McGuire

4 joint publications

Barry Slobedman

4 joint publications

Lauren Stern

4 joint publications

David C Bishop